美股市场个股详情

NGNE Neurogene

添加自选
  • 34.130
  • -1.850-5.14%
收盘价 07/05 16:00 (美东)
  • 35.020
  • +0.890+2.61%
盘后 18:21 (美东)
4.43亿总市值-12051市盈率TTM

Neurogene股票讨论区

登录发表评论
    $Neurogene(NGNE.US)$
    NEWS
    Neurogene Announces Upcoming Presentation of Safety Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome at ASGCT Meeting
    NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that initial safety and tolerability data from its ongoing Phase 1/2 gene therapy clinical trial for Rett syndrome will be ...

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议
美股
综合热度
股票代码
最新价
涨跌幅